Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 1, 2005, Pages 57-70

  Monk, Brian C ^a   Niimi, Kyoko ^a   Lin, Susan ^a   Knight, Allison ^a   Kardos, Thomas B ^a   Cannon, Richard D ^a   Parshot, Rekha ^b   King, Amanda ^b   Lun, David ^b   Harding, David R K ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; FLUCONAZOLE; FUNGICIDE; ITRACONAZOLE; OCTAPEPTIDE; PENTAPEPTIDE; PEPTIDE DERIVATIVE; PYRROLE DERIVATIVE; STEROL 14ALPHA DEMETHYLASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DNA LIBRARY; DRUG TARGETING; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; AZOLES; CANDIDA; CANDIDA ALBICANS; CELL LINE; CELL MEMBRANE; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE LIBRARY; PROTON-TRANSLOCATING ATPASES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 19944426581     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.1.57-70.2005     Document Type: Article

References (44)

1. Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40:2835-2841.
2. Bagnat, M., S. Keranen, A. Shevchenko, and K. Simons. 2000. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc. Natl. Acad. Sci. USA 97:3254-3259.
3. Decottignies, A., B. Rogers, M. Kowlaczkowski, E. Carvajal, E. Balzi, G. Conseil, K. Niimi, A. Di Pietro, B. C. Monk, and A. Goffeau. 2002. The pleiotropic drug ABC transporters from Saccharomyces cerevisiae, p. 157-176. In I. T. Paulsen and K. Lewis (ed.), Microbial multidrug efflux. Horizon Scientific Press, Wymondham, United Kingdom.
4. De Lucca, A. J., and T. J. Walsh. 1999. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother. 43:1-11.
5. Eraso, P., A. Cid, and R. Serrano. 1987. Tight control of the amount of yeast plasma membrane ATPase during changes in growth conditions and gene dosage. FEBS Lett. 224:193-197.
6. Fukuoka, T., D. A. Johnston, C. A. Winslow, M. J. de Groot, C. Burt, C. A. Hitchcock, and S. G. Filler. 2003. Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei Antimicrob. Agents Chemother. 47:1213-1219.
7. Giacometti, A., O. Cironi, R. Ghiselli, L. Goffi, F. Moccheggiani, A. Riva, G. Scalise, and V. Saba. 2000. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. Antimicrob. Agents Chemother. 44:3306-3309.
8. Hancock, R. E., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
9. Hancock, R. E., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97:8856-8861.
10. Hancock, R. E. W., and R. Lehrer. 1998. Cationic peptides; a new source of antibiotics. Trends Biotechnol. 16:82-88.
11. Helmerhorst, E. J., W. Van't Hof, E. C. Veerman, I. Simoons-Smit, and A. V. Nieuw Amerongen. 1997. Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem. J. 326:39-45.
12. Hong, S. Y., T. G. Park, and K. H. Lee. 2001. The effect of charge increase on the specificity and activity of a short antimicrobial peptide. Peptides 22:1669-1674.
13. Houghten, R. A., C. Pinilla, S. E. Blondelle, J. R. Appel, C. T. Dooley, and J. H. Cuevo. 1991. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354:84-86.
14. +-ATPase. Science 297:1692-1696.
15. Kundu, B., T. Srinivasan, A. P. Kesarwani, A. Kavishwar, S. K. Raghuwanshi, S. Batra, and P. K. Shukla. 2002. Identification of novel antifungal nonapeptides through the screening of combinatorial peptide libraries based on a hexapeptide motif. Bioorg. Med. Chem. Lett. 12:1473-1476.
16. Li, X. S., M. S. Reddy, D. Baev, and M. Edgerton. 2003. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J. Biol. Chem. 278:28553-28561.
17. Lopez-Garcia, B., E. Perez-Paya, and J. F. Marcos. 2002. Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library. Appl. Environ. Microbiol. 68:2453-2460.
18. Marti-Renom, M. A., A. C. Stuart, A. Fiser, R. Sanchez, F. Melo, and A. Sali. 2000. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29:291-325.
19. +-ATPase. Biochim. Biophys. Acta 1372:261-271.
20. +-ATPases. Biochim. Biophys. Acta 1284:181-191.
21. Mitchell, D. J., D. T. Kim, L. Steinman, C. G. Fathman, and J. B. Rothbard. 2000. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56:318-325.
22. Monk, B., and A. Goffeau. 2000. Platforms for antifungal discovery in the 21st century. Biochemist 20:20-25.
23. Monk, B. C., R. D. Cannon, K. Nakamura, M. Niimi, K. Niimi, D. R. K. Harding, A. R. Holmes, E. Lamping, A. Goffeau, and A. Decottignies. March 2003. Membrane protein expression system and its application in drug screening. International provisional patent PCT/NZ02/00163.
24. +-ATPase from Candida albicans. J. Bacteriol. 173:6826-6836.
25. Monk, B. C., A. B. Mason, G. Abramochkin, J. E. Haber, D. Seto-Young, and D. S. Perlin. 1995. The yeast plasma membrane proton pumping ATPase is a viable antifungal target. 1. Effects of the cysteine-modifying reagent omeprazole. Biochim. Biophys. Acta 1239:81-90.
26. +-ATPase. J. Biol. Chem. 266:18097-18103.
27. +-ATPase during yeast growth and germ tube formation. J. Bacteriol. 175:5566-5574.
28. Monk, B. C., and D. S. Perlin. 1994. Fungal plasma membrane proton pumps as promising new antifungal targets. Crit. Rev. Microbiol. 20:209-233.
29. +-ATPase mutant pma1-A135V and its revertants. J. Biol. Chem. 268:11792-11797.
30. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2001. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374.
31. Niimi, K., D. R. K. Harding, R. Parshot, A. King, D. J. Lun, A. Decottignies, M. Niimi, S. Lin, R. D. Cannon, A. Goffeau, and B. C. Monk. 2004. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob. Agents Chemother. 48:1256-1271.
32. Niimi, M., Y. Nagai, K. Niimi, S. Wada, R. D. Cannon, Y. Uehara, and B. C. Monk. 2002. Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J. Chromatogr. B 782:245-252.
33. Ostresh, J. M., S. E. Blondelle, B. Dorner, and R. A. Houghten. 1996. Generation and use of nonsupport-bound peptide and peptidomimetic combinatorial libraries. Methods Enzymol. 267:220-234.
34. Pinilla, C., J. R. Appel, P. Blanc, and R. A. Houghten. 1992. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. BioTechniques 13:901-905.
35. Portillo, F., and R. Serrano. 1989. Growth control strength and active site of yeast plasma membrane ATPase studied by site-directed mutagenesis. Eur. J. Biochem. 186:501-507.
36. 2+-ATPase. Nature 319:689-693.
37. +-ATPase of fungi. Biochim. Biophys. Acta 1326:249-256.
38. Shi, Z., C. A. Olson, and N. R. Kallenbach. 2002. Cation-pi interaction in model alpha-helical peptides. J. Am. Chem. Soc. 124:3284-3291.
39. Strom, M. B., O. Rekdal, and J. S. Svendsen. 2002. Antimicrobial activity of short arginine- and tryptophan-rich peptides. J. Pept. Sci. 8:431-437.
40. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1996. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance. Antimicrob. Agents Chemother. 40:2443-2446.
41. Wada, S., M. Niimi, K. Niimi, A. R. Holmes, B. C. Monk, R. D. Cannon, and Y. Uehara. 2002. Candida glabrata ABC transporters Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation-dependent pumping properties. J. Biol. Chem. 277:46809-46821.
42. Wakabayashi, H., H. Matsumoto, S. Terguchi, M. Takase, and H. Hayasawa. 1999. N-acylated and D-enantiomer derivatives of a nanomer core peptide of lactoferrin B showing improved antimicrobial activity. Antimicrob. Agents Chemother. 43:1267-1269.
43. White, T., K. Marr, and R. Bowden. 1998. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
44. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.